ClearMed
NeurologyReal-World Cohort5 min read

When Systems Talk-Measuring Neurology Care in the Digital Era: Emerging Issues in Neurology

Priorities include expanding neurologic data models and terminologies, ensuring that dQMs reflect clinical realities, strengthening governance across registries and networks, and enabling interoperable workflows that support remote monitoring and AI-enabled analytics.

Published in NeurologyEHR Cohort study
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

Together, these strategies position interoperability as a strategic imperative for the future of neurologic care, quality measurement, and research. These examples highlight the potential of shared terminologies, structured neurologic observations, and API-enabled exchange, while underscoring persistent challenges, including limited availability of discrete neurologic data elements and the substantial effort required for mapping and governance.

What Changes?

Neurology · Real-World Cohort

Current Standard

Conventional neurology practice relies on standard-of-care monitoring and existing regimens prior to this ehr cohort study.

New Finding

As the neurology ecosystem prepares for USCDI-aligned interoperability mandates taking effect in 2026, the neurology community plays a critical leadership role.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    As these data sources proliferate, interoperability has emerged as a foundational requirement for high-quality neurologic care.

  2. 02Study Evidence

    Tested in a ehr cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

What This Means for You

These examples highlight the potential of shared terminologies, structured neurologic observations, and API-enabled exchange, while underscoring persistent challenges, including limited availability of discrete neurologic data elements and the substantial effort required for mapping and governance. As the neurology ecosystem prepares for USCDI-aligned interoperability mandates taking effect in 2026, the neurology community plays a critical leadership role. Priorities include expanding neurologic data models and terminologies, ensuring that dQMs reflect clinical realities, strengthening governance across registries and networks, and enabling interoperable workflows that support remote monitoring and AI-enabled analytics. Together, these strategies position interoperability as a strategic imperative for the future of neurologic care, quality measurement, and research.

The Discovery

Neurology is entering a decade in which rapid growth in diagnostic technologies, data streams, and care delivery models collides with persistent fragmentation of neurologic information across electronic health records, imaging systems, and remote monitoring platforms. As these data sources proliferate, interoperability has emerged as a foundational requirement for high-quality neurologic care. The current landscape limits longitudinal understanding of disease trajectories, impedes care transitions, burdens quality measurement, and constrains research. This article articulates the current and future challenges of interoperability for neurology by characterizing the current state of interoperability; surveying relevant national standards and platforms; identifying key technical, semantic, and organizational barriers; and proposing future goals for improving interoperable neurologic care. Part and parcel of these challenges and goals are the evolving regulatory and policy frameworks, including the Trusted Exchange Framework and Common Agreement, provisions of the 21st Century Cures Act, and federal interoperability rules that mandate standardized, Fast Healthcare Interoperability Resources (FHIR)-based application programming interfaces (APIs), and a common data foundation such as the United States Core Data for Interoperability Version-3 (USCDI v3). In parallel, Centers for Medicare & Medicaid Services (CMS) initiatives have accelerated the transition to digital quality measures (dQMs), increasing the need for automated, multisource, standards-based data exchange aligned with real-time quality improvement. Using hypothetical use cases in vascular and behavioral neurology, we demonstrate how FHIR-based implementation guides could replace manual stroke quality reporting and enable the migration of cognitive assessment measures from legacy electronic clinical quality measures (eCQMs) to interoperable FHIR eCQMs, laying the groundwork for future dQMs.

How It Works, Simply

This neurology research focuses on AI model. Researchers evaluated it using an eHR Cohort study at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    As these data sources proliferate, interoperability has emerged as a foundational requirement for high-quality neurologic care.

  2. 02Study Evidence

    Tested in a ehr cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

01

Biological Mechanism & Study Design

Study Design & Cohort

EHR Cohort study

EHR Cohort study · Real-World Cohort

Biological Pathway & Modality

AI model

Intervention: When Systems Talk-Measuring Neurology Care in the Digital Era: Emerging Issues in

02

Experimental Findings & Endpoints

Neurology is entering a decade in which rapid growth in diagnostic technologies, data streams, and care delivery models collides with persistent fragmentation of neurologic information across electronic health records, imaging systems, and remote monitoring platforms.

As these data sources proliferate, interoperability has emerged as a foundational requirement for high-quality neurologic care. The current landscape limits longitudinal understanding of disease trajectories, impedes care transitions, burdens quality measurement, and constrains research.

This article articulates the current and future challenges of interoperability for neurology by characterizing the current state of interoperability; surveying relevant national standards and platforms; identifying key technical, semantic, and organizational barriers; and proposing future goals for improving interoperable neurologic care. Part and parcel of these challenges and goals are the evolving regulatory and policy frameworks, including the Trusted Exchange Framework and Common Agreement, provisions of the 21st Century Cures Act, and federal interoperability rules that mandate standardized, Fast Healthcare Interoperability Resources (FHIR)-based application programming interfaces (APIs), and a common data foundation such as the United States Core Data for Interoperability Version-3 (USCDI v3).

In parallel, Centers for Medicare & Medicaid Services (CMS) initiatives have accelerated the transition to digital quality measures (dQMs), increasing the need for automated, multisource, standards-based data exchange aligned with real-time quality improvement. Using hypothetical use cases in vascular and behavioral neurology, we demonstrate how FHIR-based implementation guides could replace manual stroke quality reporting and enable the migration of cognitive assessment measures from legacy electronic clinical quality measures (eCQMs) to interoperable FHIR eCQMs, laying the groundwork for future dQMs.

03

Clinical Translation & Practice Context

These examples highlight the potential of shared terminologies, structured neurologic observations, and API-enabled exchange, while underscoring persistent challenges, including limited availability of discrete neurologic data elements and the substantial effort required for mapping and governance.

As the neurology ecosystem prepares for USCDI-aligned interoperability mandates taking effect in 2026, the neurology community plays a critical leadership role. Priorities include expanding neurologic data models and terminologies, ensuring that dQMs reflect clinical realities, strengthening governance across registries and networks, and enabling interoperable workflows that support remote monitoring and AI-enabled analytics.

Together, these strategies position interoperability as a strategic imperative for the future of neurologic care, quality measurement, and research.

03

The Bottom Line · Clinical Pearl

“Together, these strategies position interoperability as a strategic imperative for the future of neurologic care, quality measurement, and research. These examples highlight the potential of shared terminologies, structured neurologic observations, and API-enabled exchange, while underscoring persistent challenges, including limited availability of discrete neurologic data elements and the substantial effort required for mapping and governance.”

Published in Neurology · Current Stage: Real-World Cohort

Neurology · Real-World Cohort
Study Type
EHR Cohort study

EHR Cohort study

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
EHR Cohort study in neurology care
Intervention & Mechanism
When Systems Talk-Measuring Neurology Care in the Digital Era: Emerging Issues in

AI model

Key Limitation
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as EHR Cohort study along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

Original Publication & AMA Citation

When Systems Talk-Measuring Neurology Care in the Digital Era: Emerging Issues in Neurology. Neurology. Published 2026;Nov 15. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/43019493/

Neurology

https://pubmed.ncbi.nlm.nih.gov/43019493/

Read Original Paper

Continue Reading

Related in Neurology

View all Neurology briefings →
Neurology editorial photograph for Opinion & Special Articles: Mobile Stroke Treatment Unit: A Distinctive Learning Experience in Neurology Residency
NEUROLOGY · GUIDELINE / OPINION

Opinion & Special Articles: Mobile Stroke Treatment Unit: A Distinctive Learning Experience in Neurology Residency

How a 'Hospital on Wheels' is Training the Next Generation of Stroke Doctors. Future neurologists are getting hands-on experience treating strokes in an ambulance, bridging the gap between classroom learning and real-world emergencies.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurology
Neurology editorial photograph for Personality Correlates of Functional Status in Patients With Early-Stage Behavioral Variant Frontotemporal Dementia
NEUROLOGY · REAL-WORLD COHORT

Personality Correlates of Functional Status in Patients With Early-Stage Behavioral Variant Frontotemporal Dementia

Is a personality change an early warning sign of dementia? Changes in personality, particularly a drop in conscientiousness, could signal early functional decline in people with a type of dementia called bvFTD.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurology
NEUROLOGY · REAL-WORLD COHORT

Sex Differences in Blood Pressure Dynamics and Outcomes After Endovascular Thrombectomy

Blood Pressure After Stroke: One Size Doesn't Fit All, Especially for Men and Women. After a stroke, how doctors manage blood pressure might need to be different for men and women.

5/5 Gold Standard
Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readNeurology